Literature DB >> 12576090

Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice.

Edward W Lee1, Derrick S Grant, Sharareh Movafagh, Zofia Zukowska.   

Abstract

Which of Y1-Y5 receptors (Rs) mediate NPY's angiogenic activity was studied using Y2R-null mice and R-specific antagonists. In Y2R-null mice, NPY-induced aortic sprouting and in vivo Matrigel capillary formation were decreased by 50%; Y1R-antagonist blocked the remaining response. NPY-induced sprouting was equally inhibited by Y2R- (and Y5R- but less by Y1R-) antagonists in wild type mice. Spontaneous and NPY-induced revascularization of ischemic gastrocnemius muscles were similarly reduced in Y2R-null mice. Thus, NPY-induced angiogenesis, spontaneous and ischemic, is primarily mediated by Y2Rs. However, Y5Rs and, to a lesser degree Y1Rs, also may play a role in NPY-mediated angiogenesis. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576090     DOI: 10.1016/s0196-9781(02)00281-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  20 in total

Review 1.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

2.  Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Authors:  Susana Galli; Arlene Naranjo; Collin Van Ryn; Jason U Tilan; Emily Trinh; Chao Yang; Jessica Tsuei; Sung-Hyeok Hong; Hongkun Wang; Ewa Izycka-Swieszewska; Yi-Chien Lee; Olga C Rodriguez; Chris Albanese; Joanna Kitlinska
Journal:  Am J Pathol       Date:  2016-10-12       Impact factor: 4.307

3.  Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease.

Authors:  Sara P C Paiva; Clara A Veloso; Fernanda F C Campos; Márcia M Carneiro; Jason U Tilan; Hongkun Wang; Jason G Umans; Zofia Zukowska; Joanna Kitlinska
Journal:  Neuropeptides       Date:  2015-09-25       Impact factor: 3.286

Review 4.  Stress, NPY and vascular remodeling: Implications for stress-related diseases.

Authors:  Lydia E Kuo; Ken Abe; Zofia Zukowska
Journal:  Peptides       Date:  2007-01-22       Impact factor: 3.750

5.  Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines.

Authors:  Divya Pankajakshan; Guanghong Jia; Iraklis Pipinos; Steve H Tyndall; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2011-02-23       Impact factor: 3.362

6.  Plasticity of Arterial and Venous Endothelial Cell Identity: Some Nerve!

Authors:  Basak Icli; Mark W Feinberg
Journal:  Circ Res       Date:  2016-08-19       Impact factor: 17.367

7.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

8.  In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.

Authors:  James R Shoblock; Natalie Welty; Diane Nepomuceno; Brian Lord; Leah Aluisio; Ian Fraser; S Timothy Motley; Steve W Sutton; Kirsten Morton; Ruggero Galici; John R Atack; Lisa Dvorak; Devin M Swanson; Nicholas I Carruthers; Curt Dvorak; Timothy W Lovenberg; Pascal Bonaventure
Journal:  Psychopharmacology (Berl)       Date:  2009-12-02       Impact factor: 4.530

9.  Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression.

Authors:  Jason Tilan; Joanna Kitlinska
Journal:  J Oncol       Date:  2010-05-20       Impact factor: 4.375

10.  Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.

Authors:  C Lu; L Everhart; J Tilan; L Kuo; C-C J Sun; R B Munivenkatappa; A-C Jönsson-Rylander; J Sun; A Kuan-Celarier; L Li; K Abe; Z Zukowska; J A Toretsky; J Kitlinska
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.